UB
RCUS icon

UMB Bank’s Arcus Biosciences RCUS Stock Holding History

UMB Bank’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6K Buy
570
+15
+3% +$371 ﹤0.01% 1724
2026
Q1 		$12K Buy
555
+72
+15% +$1.55K ﹤0.01% 1792
2025
Q4 		$11.5K Buy
483
+101
+26% +$2.06K ﹤0.01% 1772
2025
Q3 		$5.2K Buy
382
+78
+26% +$811 ﹤0.01% 1871
2025
Q2 		$2.48K Buy
304
+160
+111% +$1.37K ﹤0.01% 1975
2025
Q1 		$1.13K Buy
144
+26
+22% +$301 ﹤0.01% 2026
2024
Q4 		$1.76K Sell
118
-17
-13% -$278 ﹤0.01% 1967
2024
Q3 		$2.06K Buy
135
+66
+96% +$1.04K ﹤0.01% 1979
2024
Q2 		$1.05K Buy
69
+47
+214% +$759 ﹤0.01% 1962
2024
Q1 		$415 Buy
+22
New +$380 ﹤0.01% 2023

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

UMB Bank's RCUS Position: Q2 2026 in Review

UMB Bank increased its Arcus Biosciences (RCUS) stake by 2.7% in Q2 2026, buying an estimated $371 and bringing the position to 570 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1724.

UMB Bank first reported a position in RCUS in Q1 2024 and has held it in 10 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • UMB Bank held 570 shares of Arcus Biosciences worth $17.6K as of Q2 2026.
  • UMB Bank bought 15 Arcus Biosciences shares in Q2 2026, an estimated $371.
  • Arcus Biosciences made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1724 holding.
  • UMB Bank first reported a position in Arcus Biosciences in Q1 2024 and has held it in 10 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.